2 completed, 1 unknown, 1 withdrawn. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
Follow Myanmar Liver Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatitis C Treatment Study in Myanmar Sofosbuvir 400 mg - Hepatitis C | Withdrawn | Myanmar Oxford Clinical Research Unit | 2022-01-01 | 2021-12-17 | ||
| Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) Xpert HCV VL - Hepatitis C | Not applicable | Completed | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 634 | 2019-01-30 | 2021-02-02 |
| Stop Hep B @ Birth Tenofovir Disoproxil Fumarate 300 mg daily; HBV birth dose vaccine; hepatitis B immune globulin (HBIG), Regular Myanmar treatment - Hepatitis B | Not applicable | Unknown | Myanmar Liver Foundation | 110 | 2018-07-01 | 2021-08-10 |
| Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar sofosbuvir 400 mg/velpatasvir 100 mg (SOF/VEL) orally once daily for 12 weeks with or without weight-based ribavirin. - Hepatitis C, Hepatitis B | Completed | Right to Care | 803 | 2017-12-20 | 2019-07-29 |
Hepatitis C (3) · Hepatitis B (2) · HIV Infections (1)
Sofosbuvir (2) · Tenofovir (1) · daclatasvir (1) · hepatitis B hyperimmune globulin (1) · velpatasvir (1)
Burma (4)
Adam K Richards, MD (1) · Charles Chasela, PhD (1) · Hla Htay (1) · Ian Sanne, MBBCH,FRCP (1) · Khin Phone Kyi, MD (1) · Khin Pyone Khi, MBBS,FRCP,PhD (1) · Khin Pyone Kyi, MB BS (1) · Margaret Hellard (1) · Ni Ni Tun, MB BS (1)